Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas

被引:9
|
作者
Deng, Xiangyang [1 ]
Yang, Xionggang [2 ]
Yang, Chunlei [1 ]
Chen, Kezhu [1 ]
Ren, Junwei [1 ]
Zeng, Jun [1 ]
Zhang, Quan [1 ]
Li, Tianwen [1 ]
Tang, Qisheng [1 ]
Zhu, Jianhong [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Inst Brain Sci, Inst Neurosurg,Dept Neurosurg,Shanghai Med Coll,Na, Shanghai, Peoples R China
[2] Fudan Univ, Dept Orthopaed Surg, Huashan Hosp, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
socioeconomic deprivation; primary central nervous system lymphoma; SEER; overall survival (OS); cancer-specific survival; PRIMARY CNS LYMPHOMA; ELDERLY-PATIENTS; UNITED-STATES; NEIGHBORHOOD; RACE/ETHNICITY; DISADVANTAGE; DISPARITIES; DIAGNOSIS;
D O I
10.3389/fonc.2022.929585
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo our knowledge, the impact of area-level socioeconomic status (SES) has not yet been described in primary central nervous system lymphomas (PCNSLs). Current study sought to explore the association of socioeconomic deprivation, measured using the Area Deprivation Index (ADI), with PCNSL outcomes. MethodsThe Surveillance, Epidemiology, and End Results (SEER) database was used to identify PCNSL patients diagnosed between 2006 and 2015 for our analyses. The impact of ADI on overall survival (OS) and cancer-specific survival (CSS) were investigated. Survival analyses were conducted using Kaplan-Meier method with log-rank tests. The Inverse Probability Weighting (IPW) analysis and multivariate cox proportional hazards regression analysis were employed to make covariate adjustments. Multiple mediation analysis (MMA) was performed to estimate the mediating effects. ResultsA total of 3159 PCNSL patients classified into low and high ADI subgroups according to the median ADI score were studied. The Kaplan-Meier analyses showed that low ADI was significantly associated with higher OS rates (HR 1.15, 95%CI 1.06-1.26, P<0.01) and CSS rates (HR 1.15, 95%CI 1.05-1.27, P<0.01). Similar results were observed in analyses adjusted via IPW and multivariate cox methods. Subgroup analyses revealed that ADI could remain a prognostic indictor among different subsets. MMA revealed that several factors including chemotherapy and HIV status making up about 40% of the overall effect, mediated PCNSL survival disparities related to the ADI. Finally, multivariable logistic regression analysis showed that ADI as well as several other factors were independently related to receipt of chemotherapy. ConclusionsOur study highlights the role of area-level SES in prognosis of PCNSLs. And several factors including chemotherapy and HIV status of PCNSL patents contributed to the CSS disparities between ADI subgroups were uncovered by MMA. Such relationships would highlight the importance of policies development to enhance healthcare delivery and promote awareness of HIV prevention and treatment in low-resource neighborhoods.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Immunoglobulin Repertoire of Primary Lymphomas of the Central Nervous System
    Montesinos-Rongen, Manuel
    Purschke, Frauke
    Kueppers, Ralf
    Deckert, Martina
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (12) : 1116 - 1125
  • [12] PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - AN UPDATE
    JELLINGER, KA
    PAULUS, W
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 119 (01) : 7 - 27
  • [13] Novel Therapies for Primary Central Nervous System Lymphomas
    Aquilanti, Elisa
    Herrity, Elizabeth
    Nayak, Lakshmi
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2024, 24 (12) : 621 - 629
  • [14] The role of surgery in primary central nervous system lymphomas
    Francisco Villalonga, Juan
    Alessandro, Lucas
    Franco Farez, Mauricio
    Mormandi, Ruben
    Cervio, Andres
    Condomi Alcorta, Santiago
    Muggeri, Alejandro
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2018, 76 (03) : 139 - 144
  • [15] European survey on neurosurgical management of primary central nervous system lymphomas and preoperative corticosteroid therapy
    Scheichel, Florian
    Popadic, Branko
    Pinggera, Daniel
    Jaskolski, Dariusz J.
    Lubrano, Vincent
    Foroglou, Nicolas
    Netuka, David
    Iliescu, Bogdan
    Novak, Laszlo
    Sherif, Camillo
    Marhold, Franz
    Freyschlag, Christian F.
    BRAIN AND SPINE, 2023, 3
  • [16] Pathology and new insights in central nervous system lymphomas
    Lebrun, Laetitia
    Allard-Demoustiez, Sacha
    Salmon, Isabelle
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (05) : 347 - 356
  • [17] Neighborhood Socioeconomic Deprivation and Mortality in Children with Central Nervous System Tumors
    Fahmideh, Maral Adel
    Schraw, Jeremy M.
    Chintagumpala, Murali
    Lupo, Philip J.
    Oluyomi, Abiodun Olufemi
    Scheurer, Michael E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (12) : 2278 - 2285
  • [18] Characterizing second line and beyond therapies for primary central nervous system lymphomas
    Primeaux, Brian
    Luo, Chelsea
    Yeung, Erin K.
    Linger, Caitlin
    Chen, Sheree
    Do, Bryan
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (06)
  • [19] Intraoperative rapid diagnosis of primary central nervous system lymphomas: Advantages and pitfalls
    Sugita, Yasuo
    Terasaki, Mizuhiko
    Nakashima, Shinji
    Ohshima, Koichi
    Morioka, Motohiro
    Abe, Hideyuki
    NEUROPATHOLOGY, 2014, 34 (05) : 438 - 445
  • [20] Molecular profiling of primary central nervous system lymphomas - predictive and prognostic value?
    Ho, K. Grace
    Grommes, Christian
    CURRENT OPINION IN NEUROLOGY, 2019, 32 (06) : 886 - 894